Clinical Trial At VUMC Tests Novel Treatment For Asthma
November 12, 2022
November 12, 2022
NASHVILLE, Tennessee, Nov. 12 (TNSres) -- Vanderbilt University Medical Center issued the following news:
A clinical trial that will test a novel treatment for asthma has begun enrolling patients.
The treatment -- semaglutide -- is a medication approved to help control blood sugar in people with Type 2 diabetes and for weight management in obese or overweight adults. Semaglutide is one of seven approved GLP-1 receptor agonists that target a metabolic pathway to increase . . .
A clinical trial that will test a novel treatment for asthma has begun enrolling patients.
The treatment -- semaglutide -- is a medication approved to help control blood sugar in people with Type 2 diabetes and for weight management in obese or overweight adults. Semaglutide is one of seven approved GLP-1 receptor agonists that target a metabolic pathway to increase . . .